HOME >> BIOLOGY >> NEWS
NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record

A mild case of malaria smoldered in a 74-year-old woman for decades before being correctly diagnosed and successfully treated by a research physician affiliated with the National Institute of Allergy and Infectious Diseases (NIAID), according to a report in this weeks New England Journal of Medicine.

The unusual case at more than 46 years, and possibly up to 71 years, the longest known malaria infection on record "reveals how high-tech medicine can shed light even on ancient syndromes," says Joseph M. Vinetz, M.D., a postdoctoral fellow in NIAIDs Laboratory of Parasitic Diseases.

Using an extremely sensitive test that searches for genetic signature sequences of a specific malaria parasite, Dr. Vinetz found evidence of that parasite that had eluded detection in multiple standard smears of blood taken from the patient and examined under a microscope. The genetic test, RT-PCR (reverse transcription-polymerase chain reaction), had recently been developed in the laboratory of an NIAID colleague, Thomas F. McCutchan, Ph.D., primarily for research purposes.

The woman, a native of Greece, came to Dr. Vinetz attention in February 1996 when her daughter, a resident of Baltimore, brought her mother for evaluation to a Johns Hopkins University clinic where Dr. Vinetz works part time. On examination, the woman did not complain of any symptoms but did have an enlarged spleen.

The enlarged spleen, her medical history indicated, was first documented several years earlier during a routine examination in Greece. At that time, she was mistakenly diagnosed with lymphoma and treated with an oral anti-cancer drug, methotrexate, for 10 days.

In response to the chemothera
'"/>

Contact: Laurie K. Doepel
ldoepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
4-Feb-1998


Page: 1 2 3

Related biology news :

1. TIGR and NIAID sign $65 million microbial sequencing contract
2. NIAID unveils bioterrorism research agenda
3. NIAID takes next genome step
4. NIAID awards grant to rapidly sequence the malaria mosquito genome
5. NIAID launches major step in trial of experimental shingles vaccine
6. NIAID-Supported Scientists Discover Origin Of HIV-1
7. NIAID Scientists Discover HIV Disease-Slowing Mutation
8. Doctors neckties: a reservoir for bacteria?
9. Doctors miss chances to help pregnant women quit smoking
10. Doctors miss chance to advise women of vitamin that prevents birth defects, survey finds
11. Doctors perform more IVF treatments, but multiple births decline

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2018)... ... August 30, 2018 , ... In recent ... component of drug discovery programs. Longer-target engagement can result in improved efficacy and ... require expensive instrumentation, or require the alteration of the molecules involved. The limitations ...
(Date:8/29/2018)... ... August 28, 2018 , ... ... company unlocking the full power of positron emission tomography (PET), today launched ... Fuzionaire Dx is helping clinicians and researchers study and cure debilitating diseases, ...
(Date:8/23/2018)... ... , ... Mandy is an eight-year-old mini Australian shepherd and a tripod. When Mandy was four ... three surgeries to try to repair the leg and each time it was unsuccessful. ... owner, along with her veterinarian, decided to amputate. With only one front leg, mobility ...
Breaking Biology News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... Next-generation genomic sequencing is transforming what ... technologies, challenges remain. In the past, the sheer size of genomics data has made ... a new data ecosystem developed to advance cures by reducing the technological barriers to ...
(Date:9/12/2018)... ... 2018 , ... Sterlitech Corporation, a global leader in custom ... Fluid Technology Solutions (FTS H2O) to their offering of filtration products. , ... (CTA) material. The highly hydrophilic nature of the CTA FO membranes favors proper ...
(Date:9/7/2018)... (PRWEB) , ... September 06, 2018 , ... ... a fatal neuromuscular disease, has been validated to be as effective as manual ... of Dystrophin Staining in Frozen Muscle Biopsies,” was published in the Archives of ...
(Date:8/29/2018)... ... 2018 , ... Nanovis , an innovative and fast-growing ... a $5.5 million funding round managed by Commenda Securities. Key investors include Elevate ... Ventures. , “Our investment in Nanovis is consistent with our mission to support ...
Breaking Biology Technology:
Cached News: